New Daily Persistent Headache Survey
NDPH
1 other identifier
observational
803
1 country
1
Brief Summary
Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey. Research design: Online survey of patients with new daily persistent headache. Risks: Risks include a breach of confidentiality as well as fatigue from taking the survey online. Importance of knowledge that may recently be expected to result: The study aims to discover new information in a very understudied disease. This information could, in future studies, help change the diagnostic criteria or lead to new treatment options.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 19, 2023
CompletedFirst Submitted
Initial submission to the registry
July 30, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedFebruary 18, 2026
February 1, 2026
8 months
July 30, 2023
February 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survey data
At study completion, expected to be in 6-12 months.
Study Arms (1)
New daily persistent headache (NDPH) group
Participants with NDPH will be administered an online survey.
Eligibility Criteria
The population is participants with a diagnosis of NDPH. The NDPH diagnosis must come from a physician and will be further assessed with disease-specific survey questions.
You may qualify if:
- Patients with NDPH that have been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)
You may not qualify if:
- Unable to speak English (the survey is only in English)
- Unable to use a computer to take the online survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UTHealth Houston
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 30, 2023
First Posted
August 9, 2023
Study Start
June 19, 2023
Primary Completion
January 31, 2024
Study Completion
January 31, 2024
Last Updated
February 18, 2026
Record last verified: 2026-02